eISSN: 2500-7106 / ISSN: 0123-2576
Register
Login
Medicinay Laboratorio
2024, Volume: 28, Issue:1 : 14-17 doi: 10.36384/01232576.694
Research Article
Impact of Severe Pre-eclampsia and Eclampsia on Fetomaternal Outcomes: A retrospective study
Received
Feb. 11, 2024
Revised
Feb. 28, 2024
Accepted
March 15, 2024
Published
March 30, 2024
Abstract
Introduction: Severe pre-eclampsia and eclampsia are life-threatening complications of pregnancy that significantly impact maternal and fetal health. This study aimed to evaluate the feto-maternal outcomes of pregnant women diagnosed with these conditions. Material and Methods: A retrospective study was conducted at a tertiary care hospital, including 90 pregnant women diagnosed with severe pre-eclampsia or eclampsia. Inclusion criteria were singleton pregnancies ≥20 weeks gestation with a confirmed diagnosis of severe pre-eclampsia or eclampsia. Exclusion criteria included multiple pregnancies, chronic hypertension, and other major medical comorbidities. Data on maternal and neonatal outcomes were collected and analyzed. Results: The study revealed high rates of adverse maternal outcomes, including placental abruption (13.3%), HELLP syndrome (8.9%), and maternal mortality (2.2%). Neonatal outcomes included preterm birth (46.7%), low birth weight (41.1%), and neonatal intensive care unit (NICU) admission (33.3%). Conclusion: Severe pre-eclampsia and eclampsia are associated with significant maternal and neonatal morbidity and mortality. Early diagnosis, timely intervention, and multidisciplinary care are essential to improve outcomes.
License
Copyright (c) Medicinay Laboratorio
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
Medicinay Laboratorio open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Recommended Articles
Medicinay Laboratorio journal thumbnail
Volume: 28, Issue:1
Citations
18 Views
160 Downloads
Share this article
Editora Médica Colombiana SA / Universidad de Antioquia
Certified Continuing Medical Education Program (PEMCC)
Email: submission@medicinaylaboratorio.com
Carrera 43C #5-33 Medellín, Colombia 050022
DOI: https://doi.org/10.36384/issn.0123-2576
Open Access Publication
Magazone managed by Biteca